Clinical Trials Browser

Completed × Adenocarcinoma × Pemetrexed × Clear all

NCT03664024 2024-08-22

KEYNOTE-782

Phase 2 Completed

118 enrolled 14 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT02498860 2021-08-06

APICAL

Phase 2 Completed

Adenocarcinoma, Lung Neoplasms

NCT00949650 2018-04-06

BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation

Phase 3 Completed

345 enrolled 23 charts 1 FDA

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00940069 2016-02-22

TPEIAL

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01565538 2014-09-15

Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma

Phase 2 Completed

123 enrolled 9 charts

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00191503 2007-01-26

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Phase 2 Completed

Adenocarcinoma